Drug Monographs
- Drug Type
- Biotech
- Brand Names
- Breyanzi
- Unique Ingredient Identifier
- 7K2YOJ14X0
Summary
Lisocabtagene maraleucel is a CAR T-cell therapy for treatment resistant or more severe B-cell lymphomas.
- Drug Type
- Small Molecule
- Chemical Formula
- C13H20N4O3
- CAS Number
- 100324-81-0
- Unique Ingredient Identifier
- L1F2Q2X956
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 3O44K14A86
- Drug Type
- Small Molecule
- Chemical Formula
- C20H26N4O
- CAS Number
- 18016-80-3
- Unique Ingredient Identifier
- E0QN3D755O